Menu
Menu
Menu
Welcome to the SCD Masterclass, my self-paced implementation of the specific carbohydrate diet. This program provides you with helpful insights, education, and a detailed action-based protocol to help you manage your IBD and drive to lasting remission.
The SCD Masterclass is a comprehensive SCD learning course for patients. It’s also an actionable program with a step-by-step protocol you can customize to achieve lasting remission for IBD. Includes: Instructional Course, Videos, Downloads, Self-assessments; 200+ SCD Recipes, Food & Symptom Logger, Mobile App, Group Support.
Welcome to the SCD Masterclass, my self-paced implementation of the specific carbohydrate diet. This program provides you with helpful insights, education, and a detailed action-based protocol to help you manage your IBD and drive to lasting remission.
My Upcoming Free Events
New 6-Week Group Program Announcement!
Path to IBD Remission
Friday September 8th, 2023 @ 11 – 11:30 AM Pacific Time
My Past Events
SCD Workshop & Podcast Library
Session #1
Session #2
Session #3
Feb 1, 2022
Dr. Ali Arjomand returns to discuss The Specific Carbohydrate Diet, DINE-CD, eating SCD illegal (but whole) foods, his My SCD(R) Protocol, and more
The SCD Specific Carbohydrate Diet Podcast
Host: Lee Bernstein
www.scdforme.com
Sep 16, 2020
Season 1 Episode 5 Dr. Ali Arjomand, PhD Nutritionist and Founder of Modulla Health
The SCD Specific Carbohydrate Diet Podcast
Host: Lee Bernstein
www.scdforme.com
February 17, 2020
The Specific Carbohydrate Diet, Reaching Remission on SCD and Feeling Liberated Not Restricted with Dr. Ali Arjomand
Plenty and Well Podcast
Host: Natalie Kelley
www.plentyandwell.com
Downloads & Resources
Nutritional Therapy for IBD (NTforIBD) Concise summary of SCD presented by this non-profit organization sharing informational on nutritional interventions in IBD. (Dr Ali Arjomand is a Founding Board Member of NTforIBD)
The Specific Carbohydrate Diet Association (SCDA) Non-profit organization raising awareness of the benefits of the Specific Carbohydrate Diet™ (SCD™). Unifying the SCD Community including followers, parents, caregivers, doctors, clinicians, companies and others around the world. (Dr Ali Arjomand is a Board Member of SCDA)
The Specific Carbohydrate Diet Association (SCDA) Non-profit organization raising awareness of the benefits of the Specific Carbohydrate Diet™ (SCD™). Unifying the SCD Community including followers, parents, caregivers, doctors, clinicians, companies and others around the world. (Dr Ali Arjomand is a Board Member of SCDA)
Breaking the Vicious Cycle (Book) by Elaine Gottschall MS (Author)
Clinical And Histologic Remission In An Adult Crohn’s Disease Patient And Its Impact On Healthcare Costs, A. Arjomand, D. Suskind. Cureus. 2022 Feb 8;14(2):e22032.
doi: 10.7759/cureus.22032. [CrossRef]
Adult Crohn’s Disease Treated With The Specific Carbohydrate Diet (SCD): Crohn’s Colitis Congress, Arjomand, A. .Poster, 2019.
Response to strict and liberalized specific carbohydrate diet in pediatric Crohn’s disease. Burgis, J.C., K. Nguyen, K.T. Park and K. Cox. World journal of gastroenterology, 2016. 22(6): p. 2111-2117. [CrossRef]
Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn’s disease. Cohen, S.A., B.D. Gold, S. Oliva, J. Lewis, A. Stallworth, B. Koch, L. Eshee and D. Mason, J Pediatr Gastroenterol Nutr, 2014. 59(4): p. 516-21. [CrossRef]
The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases. Haas, S.V. and M.P. Haas, Am J Gastroenterol, 1955. 23(4): p. 344-60. [PubMed]
The Specific Carbohydrate Diet for Inflammatory Bowel Disease: A Case Series.Kakodkar, S., A.J. Farooqui, S.L. Mikolaitis and E.A. Mutlu, J Acad Nutr Diet, 2015. 115(8): p. 1226-32. [CrossRef]
Resolution of Severe Ulcerative Colitis with the Specific Carbohydrate Diet. Khandalavala, B.N. and M.C. Nirmalraj, Case Rep Gastroenterol, 2015. 9(2): p. 291-5. [CrossRef]
Dietary Therapies in Pediatric Inflammatory Bowel Disease: An Evolving Inflammatory Bowel Disease Paradigm. Lane, E.R., D. Lee and D.L. Suskind, Gastroenterol Clin North Am, 2017. 46(4): p. 731-744. [CrossRef]
Diet to the Rescue: Cessation of Pharmacotherapy After Initiation of Exclusive Enteral Nutrition (EEN) Followed by Strict and Liberalized Specific Carbohydrate Diet (SCD) in Crohn’s Disease. Nakayuenyongsuk, W., M. Christofferson, K. Nguyen, J. Burgis and K.T. Park, Dig Dis Sci, 2017. 62(10): p. 2686-2689. [CrossRef]
The Specific Carbohydrate Diet and Diet Modification as Induction Therapy for Pediatric Crohn’s Disease: A Randomized Diet Controlled Trial. Suskind, D.L., D. Lee, Y.M. Kim, G. Wahbeh, N. Singh, K. Braly, M. Nuding, C.D. Nicora, S.O. Purvine, M.S. Lipton, J.K. Jansson and W.C. Nelson, Nutrients, 2020. 12(12). [CrossRef]
Nutritional therapy in pediatric Crohn disease: the specific carbohydrate diet. Suskind, D.L., G. Wahbeh, N. Gregory, H. Vendettuoli and D. Christie, J Pediatr Gastroenterol Nutr, 2014. 58(1): p. 87-91. [CrossRef]
Clinical and fecal microbial changes with diet therapy in active inflammatory bowel disease. Suskind, D.L., S.A. Cohen, M.J. Brittnacher, G. Wahbeh, D. Lee, M.L. Shaffer, K. Braly, H.S. Hayden, J. Klein, B. Gold and others, Journal of clinical gastroenterology, 2018. 52(2): p. 155-163. [CrossRef]
Quigley, E.M.M., Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet? Nat Rev Gastroenterol Hepatol, 2017. 14(5): p. 315-320. [CrossRef]
Albenberg, L.G. and G.D. Wu, Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology, 2014. 146(6): p. 1564-72. [CrossRef]
Vindigni, S.M., T.L. Zisman, D.L. Suskind and C.J. Damman, The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol, 2016. 9(4): p. 606-25. [CrossRef]
Hemperly, A., W.J. Sandborn and N. Vande Casteele, Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis, 2018. 24(12): p. 2527-2542. [CrossRef]
Albenberg, L.G., J.D. Lewis and G.D. Wu, Food and the gut microbiota in inflammatory bowel diseases: a critical connection. Curr Opin Gastroenterol, 2012. 28(4): p. 314-20. [CrossRef]
Lee, D., L. Albenberg, C. Compher, R. Baldassano, D. Piccoli, J.D. Lewis and G.D. Wu, Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology, 2015. 148(6): p. 1087-106. [CrossRef]
Limketkai, B.N., M. Gordon, E.A. Mutlu, P.S. De Silva and J.D. Lewis, Diet Therapy for Inflammatory Bowel Diseases: A Call to the Dining Table. Inflamm Bowel Dis, 2020. 26(4): p. 510-514. [CrossRef]
Limketkai, B.N., A. Wolf and A.M. Parian, Nutritional Interventions in the Patient with Inflammatory Bowel Disease. Gastroenterol Clin North Am, 2018. 47(1): p. 155-177. [CrossRef]
Lewis, J.D. and M.T. Abreu, Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Gastroenterology, 2017. 152(2): p. 398-414 e6. [CrossRef]
Hou, J.K., D. Lee and J. Lewis, Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol, 2014. 12(10): p. 1592-600. [CrossRef]
Nazarenkov, N., K. Seeger, L. Beeken, A.N. Ananthakrishnan, H. Khalili, J.D. Lewis and G.G. Konijeti, Implementing Dietary Modifications and Assessing Nutritional Adequacy of Diets for Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y), 2019. 15(3): p. 133-144. [PubMed]
Park, K.T., R.B. Colletti, D.T. Rubin, B.K. Sharma, A. Thompson and A. Krueger, Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn’s Disease in the United States. Am J Gastroenterol, 2016. 111(1): p. 15-23. [CrossRef]
Chiorean, M., A. Afzali, R.K. Cross, D. Macaulay, J. Griffith, A. Wang and V. Garcia-Horton, Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab. Crohn’s & Colitis 360, 2020. 2(2). [CrossRef]
Levine, A., J.M. Rhodes, J.O. Lindsay, M.T. Abreu, M.A. Kamm, P.R. Gibson, C. Gasche, M.S. Silverberg, U. Mahadevan, R.S. Boneh, E. Wine, O.M. Damas, G. Syme, G.L. Trakman, C.K. Yao, S. Stockhamer, M.B. Hammami, L.C. Garces, G. Rogler, I.E. Koutroubakis, A.N. Ananthakrishnan, L. McKeever and J.D. Lewis, Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol, 2020. 18(6): p. 1381-1392. [CrossRef]
The SCD® and Specific Carbohydrate Diet® Trademarks are owned by Kirkton Press Limited and used here under license.
